🔎 Trials Near Me

Utama › Mieloma Pelbagai › New Jersey › Clifton

Kajian klinikal Mieloma Pelbagai di Clifton, NJ

14 kajian untuk Mieloma Pelbagai sedang mencari peserta di lokasi dalam dan sekitar Clifton (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

Mengambil pesertaFasa 1/2
  • Hackensack University Medical Center, Hackensack · 7 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT04973605

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Mengambil pesertaFasa 4
  • Hackensack University Medical Center, Hackensack · 7 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05201781

Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma

Mengambil pesertaFasa 1
  • Hackensack Meridian Health - John Theurer Cancer Center, Hackensack · 7 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT03909412

A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma

Mengambil pesertaFasa 2
  • John Theurer Cancer Center, Hackensack · 7 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT04661137

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Mengambil pesertaFasa 3
  • Hackensack Meridian Health, Hackensack · 7 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07648264

A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma

Mengambil pesertaFasa 1/2
  • Hackensack University Medical Center, Hackensack · 7 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06988488

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

Mengambil pesertaFasa 1
  • John Theurer Cancer Center, Hackensack University Medical Center, Hackensack · 7 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07075185

A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma

Mengambil pesertaFasa 1/2
  • Research Site, Hackensack · 7 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT07681596

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

Mengambil pesertaFasa 1
  • Hackensack University Medical Center, Hackensack · 7 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT05651932

Mosaic Trial for Stem Cell Transplant Recipients

Mengambil peserta
  • Hackensack Meridian Health, Nutley · 3 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT06960993

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

Mengambil pesertaFasa 1
  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Jul 2026 · NCT06121843

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

Mengambil pesertaFasa 1
  • Hackensack Meridian John Theurer Cancer Center, Hackensack · 7 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2025 · NCT05722418

A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma

Mengambil pesertaFasa 1/2
  • John Theurer Cancer Center at Hackensack UMC, Hackensack · 7 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Sep 2025 · NCT05372354

Kajian Mieloma Pelbagai di bandar lain

Kajian lain di Clifton

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.